Literature DB >> 11713961

Basal and fat-stimulated plasma peptide YY levels in celiac disease.

P J Wahab1, W P Hopman, J B Jansen.   

Abstract

The distal gut hormone peptide YY (PYY) mediates feedback inhibition of gastric acid secretion, gastrointestinal motility, and pancreatic enzyme output. To investigate the influence of maldigestion on PYY, we determined plasma PYY levels in patients with celiac disease under basal conditions and in response to intraduodenal fat. Basal PYY was increased in untreated celiac patients (N = 13) compared to patients on a gluten free diet (N = 9) [15.6 (11.8-27.0) pM vs 12.2 (10.1-13.1) pM; P < 0.05] and compared to control subjects (N = 15) [9.5 (8.3-10.4) pM; P < 0.001]. Integrated PYY in response to intraduodenally infused predigested fat (1071+/-293 pM 80 min) was significantly (P < 0.05) greater than in response to undigested fat (322+/-223 pM 80 min) in six untreated celiacs. Plasma concentrations of PYY and cholecystokinin were strongly correlated (r = 0.79; P < 0.001). We conclude that basal PYY levels in untreated celiac disease are elevated, that predigestion of fat enhances PYY release in these patients, and that PYY secretion is correlated with CCK release.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11713961     DOI: 10.1023/a:1012344424300

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  40 in total

1.  Colonic fermentation and proximal gastric tone in humans.

Authors:  A Ropert; C Cherbut; C Rozé; A Le Quellec; J J Holst; X Fu-Cheng; S Bruley des Varannes; J P Galmiche
Journal:  Gastroenterology       Date:  1996-08       Impact factor: 22.682

2.  Evidence for regulation of peptide-YY release by the proximal gut.

Authors:  G H Greeley; Y J Jeng; G Gomez; T Hashimoto; F L Hill; K Kern; T Kurosky; H F Chuo; J C Thompson
Journal:  Endocrinology       Date:  1989-03       Impact factor: 4.736

3.  Adrenergic pathway in the inhibition of pancreatic secretion by peptide YY in dogs.

Authors:  S J Konturek; J Bilski; W Pawlik; J Tasler; W Domschke
Journal:  Gastroenterology       Date:  1988-02       Impact factor: 22.682

4.  Impaired release of peptide YY in patients with proctocolectomy and ileal pouch-anal anastomosis.

Authors:  P L van Battum; W P Hopman; J M Salemans; J H Kuijpers; F M Nagengast; J B Jansen
Journal:  Scand J Gastroenterol       Date:  1999-04       Impact factor: 2.423

5.  Neural regulation of peptide YY secretion.

Authors:  T Zhang; T Uchida; G Gomez; F Lluis; J C Thompson; G H Greeley
Journal:  Regul Pept       Date:  1993-11-03

6.  Correlation between peptide YY-induced myoelectric activity and transit of small-intestinal contents in rats.

Authors:  A Al-Saffar; P M Hellström; G Nylander
Journal:  Scand J Gastroenterol       Date:  1985-06       Impact factor: 2.423

7.  Exocrine pancreatic insufficiency in celiac sprue: a cause of treatment failure.

Authors:  P T Regan; E P DiMagno
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

8.  Duodenal endocrine cells in adult coeliac disease.

Authors:  K Sjölund; J Alumets; N O Berg; R Håkanson; F Sundler
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

9.  Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man.

Authors:  A Wettergren; H Petersen; C Orskov; J Christiansen; S P Sheikh; J J Holst
Journal:  Scand J Gastroenterol       Date:  1994-06       Impact factor: 2.423

10.  Increased plasma levels of peptide YY in coeliac disease.

Authors:  K Sjölund; R Ekman
Journal:  Scand J Gastroenterol       Date:  1988-04       Impact factor: 2.423

View more
  7 in total

1.  Pancreatic insufficiency in adult celiac disease: do patients require long-term enzyme supplementation?

Authors:  Kate E Evans; John S Leeds; Stephen Morley; David S Sanders
Journal:  Dig Dis Sci       Date:  2010-05-11       Impact factor: 3.199

2.  How to manage: patient with a low faecal elastase.

Authors:  Kwan Wai Lam; John Leeds
Journal:  Frontline Gastroenterol       Date:  2019-11-15

Review 3.  The role of fecal elastase-1 in detecting exocrine pancreatic disease.

Authors:  John S Leeds; Kofi Oppong; David S Sanders
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-05-31       Impact factor: 46.802

Review 4.  Obesity and appetite control.

Authors:  Keisuke Suzuki; Channa N Jayasena; Stephen R Bloom
Journal:  Exp Diabetes Res       Date:  2012-08-01

5.  The gut hormones in appetite regulation.

Authors:  Keisuke Suzuki; Channa N Jayasena; Stephen R Bloom
Journal:  J Obes       Date:  2011-09-22

6.  Increased fasting small-bowel water content in untreated coeliac disease and scleroderma as assessed by magnetic resonance imaging.

Authors:  Ching Lam; David S Sanders; Peter Lanyon; Klara Garsed; Stephen Foley; Susan Pritchard; Luca Marciani; Caroline L Hoad; Carolyn Costigan; Penny Gowland; Robin Spiller
Journal:  United European Gastroenterol J       Date:  2019-06-21       Impact factor: 4.623

7.  Gut hormones, appetite suppression and cachexia in patients with pulmonary TB.

Authors:  Suzanne W Chang; William S Pan; Daniel Lozano Beltran; Lizet Oleyda Baldelomar; Marco Antonio Solano; Iskra Tuero; Jon S Friedland; Faustino Torrico; Robert H Gilman
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.